Evidence map›Paper›PMID 38253689›Full record

ArticleEMBO reports2024

RhoGDI phosphorylation by PKC promotes its interaction with death receptor p75

Ajeena Ramanujan, Zhen Li, Yanchen Ma, Zhi Lin, Carlos F Ibáñez

Open access · diamondAbstract read
In one paragraph

Article in EMBO reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 5 countries.

Ajeena Ramanujan *Department of Physiology and Life Sciences Institute, National University of Singapore, 117456, Singapore, Singapore.ORCID 0000-0002-6843-5372
Zhen Li *Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, School of Life Sciences, Tianjin University, Tianjin, 300072, China.ORCID 0009-0005-7055-3828
Yanchen MaPeking University School of Life Sciences, PKU-IDG/McGovern Institute for Brain Research, Peking-Tsinghua Center for Life Sciences, 100871, Beijing, China.ORCID 0009-0002-2949-182X
Zhi LinTianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, School of Life Sciences, Tianjin University, Tianjin, 300072, China.
Carlos F IbáñezDepartment of Physiology and Life Sciences Institute, National University of Singapore, 117456, Singapore, Singapore. carlos.ibanez@pku.edu.cn.ORCID 0000-0003-4090-0794
National University of Singapore · SGTianjin University · CNPeking University · CN

Funding

Cancerfonden (Swedish Cancer Society) 222135Pj01HNational Natural Science Foundation of China 21974093National Research Foundation Singapore (NRF) NRF2019-NRF-ISF003-3141Vetenskapsrådet (VR) 2020-01923_3
6 · The paper itself

Abstract

How receptors juggle their interactions with multiple downstream effectors remains poorly understood. Here we show that the outcome of death receptor p75

Indexed as

NeuronsNF-kappa BAxonsLigandsPhosphorylationReceptor, Nerve Growth FactorReceptors, Death Domainrho-Specific Guanine Nucleotide Dissociation InhibitorsLigandsNF-kappa BReceptor, Nerve Growth FactorReceptors, Death Domainrho-Specific Guanine Nucleotide Dissociation InhibitorsMyelin Associated GlycoproteinNerve Growth FactorRhoARIP2

Identifiers

PMID38253689
PMCPMC10933337
OpenAlexW4391111430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.